Suchergebnisse - "Dalal, Rahul S"

PubPharm (7)

1

Tofacitinib for the Treatment of Pouch-Related Disorders : A Case Series

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Bains, K. | Marcus, J. | +2

2

Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis : A Multicenter Cohort Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Dalal, R. | Esckilsen, S. | Barnes, E. | +3

3

Endoscopy Is Not Associated with Infectious Adverse Events After Hematopoietic Cell Transplantation : A Retrospective Cohort Study

enthalten in: Digestive diseases and sciences | 2022

von Segura, A. | Dalal, R. | Golla, M. | +4

4

Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2022

von Dalal, R. | McClure, E. | Marcus, J. | +1

5

Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2022

von Dalal, R. | McClure, E. | Marcus, J. | +1

6

Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2022

von Dalal, R. | McClure, E. | Marcus, J. | +1

7

Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Gupta, S. | Goodrick, H. | +2

1
[1]